|
Omarova Kh.G., Makashova V.V., Ponezheva Zh.B.
The features of the course of HBV infection during antiviral therapy
|
№1 / 2022
|
|
Ponezheva Zh.B., Makashova V.V., Sannikova I.V., Titorenko M.V., Mannanova I.V., Patlusov E.V., Kambieva L.F., Ivanova M.R.
Experience with narlaprevir in the treatment of chronic hepatitis C
|
№2 / 2020
|
|
Ponezheva Zh.B., Makashova V.V.
Treatment with the first Russian direct-acting antiviral drug in patients with chronic hepatitis C
|
№4 / 2019
|
|
Zaitsev A.A., Akimkin V.G.
Acute bronchitis: topical issues of epidemiology, etiology, pharmacotherapy and prevention
|
№2 / 2019
|
|
Orlova S.N., Baskhanova M.V.
Efficiency of antiviral therapy for chronic hepatitis c in patients with undifferentiated connective tissue dysplasia
|
№2 / 2019
|
|
Mikhailov M.I., Kyuregyan K.K., Malinnikova E.Yu., Isaeva O.V., Karlsen A.A., Potemkin I.А., Kichatova V.S., Al-Sharabi Shukri A.S., Dogadov D.I., Korzaya L.I., Ignatieva M.E., Polyakov A.D.
Viral hepatitis: prognosis and problems
|
№1 / 2019
|
|
Zaitseva E.A., Popova L.L., Konstantinov D.Yu., Nedugov G.V.
New possibilities of predicting the outcomes of antiviral therapy in patients with chronic hepatitis B
|
№3 / 2018
|
|
Makashova V.V., Ponezheva Zh.B.
Efficiency of interferon-free therapy regimens in patients with chronic hepatitis C
|
№6 / 2017
|
|
Khaertynova I.M., Sozinova Yu.M., Galeeva N.V., Gaifullina E.G., Urmancheeva Yu.R., Gataullin M.R.
Experience of treatment with direct-acting antiviral drugs in patients with cirrhosis at the outcome of chronic hepatitis
|
№2 / 2017
|
|
Soldatova E.Yu., Melekhina E.V., Gorelov A.V.
Herpesvirus infection in patients with juvenile arthritis
|
№1 / 2017
|
|
Salman E.R., Asatryan M.N., Gaidarenko A.D., Ershov I.F., Semenenko T.A.
Predictive assessment of preventable mortality associated with chronic hepatitis C
|
№6 / 2016
|
|
Makashova V.V., Kuznetsov S.D., Tutelyan A.V., Shabalina S.V.
Clinical and genetic relationships in patients with chronic hepatitis C
|
№5 / 2016
|
Русский
